UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bone‐on‐a‐Chip: Microfluidic Technologies and Microphysiologic Models of Bone Tissue

Advanced functional materials, 2021-02, Vol.31 (6), p.n/a

2021

Volltextzugriff (PDF)

Androgen Receptor-Independent Function of FoxA1 in Prostate Cancer Metastasis

Cancer research (Chicago, Ill.), 2013-06, Vol.73 (12), p.3725-3736

2013

Volltextzugriff (PDF)

Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis

The American journal of clinical nutrition, 2014-07, Vol.100, p.431S-436S

2014

Volltextzugriff (PDF)

Circulating giant macrophages as a potential biomarker of solid tumors

Proceedings of the National Academy of Sciences - PNAS, 2014-03, Vol.111 (9), p.3514-3519

2014

Volltextzugriff (PDF)

Inhibition of cancer cell invasion and metastasis by genistein

Cancer and metastasis reviews, 2010-09, Vol.29 (3), p.465-482

2010

Volltextzugriff (PDF)

MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer

Oncogene, 2006-05, Vol.25 (21), p.2987-2998

2006

Volltextzugriff (PDF)

A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone

Journal for immunotherapy of cancer, 2020-07, Vol.8 (2), p.e000642

2020

Volltextzugriff (PDF)

The neuroinflammatory component of negative affect in patients with chronic pain

Molecular psychiatry, 2021-03, Vol.26 (3), p.864-874

2021

Volltextzugriff (PDF)

Clinical trial design: Past, present, and future in the context of big data and precision medicine

Cancer, 2020-11, Vol.126 (22), p.4838-4846

2020

Volltextzugriff (PDF)

Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial

Cancer prevention research (Philadelphia, Pa.), 2012-02, Vol.5 (2), p.309-319

2012

Volltextzugriff (PDF)

Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells

Cancer research (Chicago, Ill.), 2005-04, Vol.65 (8), p.3470-3478

2005

Volltextzugriff (PDF)

Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis

PloS one, 2014-07, Vol.9 (7), p.e102289-e102289

2014

Volltextzugriff (PDF)

Dietary Genistein Inhibits Metastasis of Human Prostate Cancer in Mice

Cancer research (Chicago, Ill.), 2008-03, Vol.68 (6), p.2024-2032

2008

Volltextzugriff (PDF)

A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4

PloS one, 2013-12, Vol.8 (12), p.e81504-e81504

2013

Volltextzugriff (PDF)

Implementing a comprehensive translational oncology platform: from molecular testing to actionability

Journal of translational medicine, 2018-12, Vol.16 (1), p.358-358, Article 358

2018

Volltextzugriff (PDF)

Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors

PloS one, 2013-08, Vol.8 (8), p.e72407-e72407

2013

Volltextzugriff (PDF)

Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment

Frontiers in oncology, 2023-08, Vol.13, p.1204726

2023

Volltextzugriff (PDF)

Endoglin Regulates Cancer-Stromal Cell Interactions in Prostate Tumors

Cancer research (Chicago, Ill.), 2011-05, Vol.71 (10), p.3482-3493

2011

Volltextzugriff (PDF)

Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression

Oncotarget, 2014-05, Vol.5 (9), p.2648-2663

2014

Volltextzugriff (PDF)

Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway

Oncogene, 2007-11, Vol.26 (51), p.7240-7250

2007

Volltextzugriff (PDF)

MEK4 Function, Genistein Treatment, and Invasion of Human Prostate Cancer Cells

JNCI : Journal of the National Cancer Institute, 2009-08, Vol.101 (16), p.1141-1155

2009

Volltextzugriff (PDF)

FDA Approval Summary: Belzutifan for VHL Disease Tumors-Letter

Clinical cancer research, 2023-02, Vol.29 (3), p.684-684

2023

Volltextzugriff (PDF)

Micronuclei in Circulating Tumor Associated Macrophages Predicts Progression in Advanced Colorectal Cancer

Biomedicines, 2022-11, Vol.10 (11), p.2898

2022

Volltextzugriff (PDF)

Damping Measurements on a Multi-Blade Cascade with Multiple Degrees of Freedom: A Francis-99 Test Case

Journal of physics. Conference series, 2019-08, Vol.1296 (1), p.12003

2019

Volltextzugriff (PDF)

Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer

Oncotarget, 2016-08, Vol.7 (33), p.52810-52817

2016

Volltextzugriff (PDF)

1 – 25 von 397

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(338)
Mit Volltextzugriff
(308)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bone‐on‐a‐Chip: Microfluidic Technologies and Microphysiologic Models of Bone Tissue

Androgen Receptor-Independent Function of FoxA1 in Prostate Cancer Metastasis

Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis

Circulating giant macrophages as a potential biomarker of solid tumors

Inhibition of cancer cell invasion and metastasis by genistein

MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer

A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone

The neuroinflammatory component of negative affect in patients with chronic pain

Clinical trial design: Past, present, and future in the context of big data and precision medicine

Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial

Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells

Mitogen-activated protein kinase kinase 4 (MAP2K4) promotes human prostate cancer metastasis

Dietary Genistein Inhibits Metastasis of Human Prostate Cancer in Mice

A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4

Implementing a comprehensive translational oncology platform: from molecular testing to actionability

Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors

Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment

Endoglin Regulates Cancer-Stromal Cell Interactions in Prostate Tumors

Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression

Endoglin inhibits prostate cancer motility via activation of the ALK2-Smad1 pathway

MEK4 Function, Genistein Treatment, and Invasion of Human Prostate Cancer Cells

FDA Approval Summary: Belzutifan for VHL Disease Tumors-Letter

Micronuclei in Circulating Tumor Associated Macrophages Predicts Progression in Advanced Colorectal Cancer

Damping Measurements on a Multi-Blade Cascade with Multiple Degrees of Freedom: A Francis-99 Test Case

Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer

Suchergebnisse filtern